2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland

2023 年国际疫苗协会 (ISV) 年会，10 月 22 日至 25 日，瑞士洛桑

• 批准号: 10754840
• 负责人: DAVID B. WEINER
• 金额: $ 0.5万
• 依托单位: INTERNATIONAL SOCIETY OF VACCINES
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-22 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10754840
• 关键词: 2019-nCoV; Academia; Acinetobacter baumannii; Address; Adjuvant; African Swine Fever Virus; Animal Model; Antibody Affinity; Antibody Response; Antigens; Area; Award; B-Lymphocyte Epitopes; B-Lymphocytes; Bone Marrow; COVID-19; COVID-19 vaccine; Cancer Vaccines; Childhood; Clinic; Clinical; Communicable Diseases; Complement; Complex; Congresses; Country; Cytotoxic T-Lymphocytes; Data; Dedications; Dengue; Development; Disease; Emerging Communicable Diseases; Ensure; Epitopes; Event; Foundations; Generations; Government; HIV Envelope Protein gp120; HIV-1; Health; Healthcare Systems; Helper-Inducer T-Lymphocyte; Human; Immune; Immune response; Immunization Programs; Immunologic Memory; Immunology; Incidence; Industry; International; Knowledge; Lead; Learning; Licensing; Malaria; Malaria Vaccines; Malignant Neoplasms; Medical; Memory B-Lymphocyte; Mentors; Messenger RNA; Molecular Conformation; Monoclonal Antibodies; Mucosal Immunity; Mucous Membrane; Multi-Drug Resistance; Multiple Bacterial Drug Resistance; Oral; Parasites; Participant; Persons; Phenotype; Plasma Cells; Plasmodium falciparum; Policies; Postdoctoral Fellow; Preparation; Prize; RNA vaccine; Research; Respiratory syncytial virus RSV F proteins; Role; SARS-CoV-2 infection; Safety; Scientist; Senior Scientist; Site; Societies; Speed; Streptococcus pyogenes; Structure; Students; Surface Antigens; Switzerland; System; T-Lymphocyte; T-cell receptor repertoire; Technology; Travel; Vaccine Antigen; Vaccine Design; Vaccine Research; Vaccines; Variant; Viral reservoir; Virus Latency; Virus-like particle; Zoonoses; cancer cell; career; career development; chronic infection; clinical development; clinical implementation; collaborative environment; cost; cost effective; design; doctoral student; expectation; fighting; health care service organization; improved; influenzavirus; insight; lipid nanoparticle; malaria transmission; manufacture; meetings; member; microbial; microorganism; mucosal vaccine; neutralizing antibody; next generation; novel vaccines; pathogen; peer; posters; prevent; programs; response; scale up; severe COVID-19; skills; structural biology; symposium; technology platform; tissue resident memory T cell; transmission blocking; vaccination strategy; vaccine candidate; vaccine effectiveness; vaccine platform; vaccinology; virtual; volunteer

Project Summary / Abstract The International Society for Vaccines (ISV) is a not-for-profit membership organization founded in 1992 with members from 44 countries, holding annual congresses since 2007. With the ISV Annual Congress, attended by member and non-member participants from 5 continents, the Society aims to highlight the very latest ground-breaking developments in vaccine research, manufacturing, clinical development and implementation, and safety. Plenary sessions are devoted to current hot topics spanning diverse areas of vaccinology, including vaccines against challenging targets, T-cell based vaccines, B cell memory establishment, structure-based vaccine design, mucosal vaccines, and vaccines against emerging infectious diseases. The ISV Congress, as the main comprehensive non-commercial vaccine meeting, strives to ensure participation of speakers and delegates from a diverse background (academic, industry, government, and foundations). Breakout sessions include topics related to adjuvant mechanisms, One Health, vaccines against zoonotic infections, and next generation vaccines. Renowned invited speakers in these fields have been and will be invited to set the stage for each of the plenary topics, complemented with oral presentations selected from the submitted abstracts. The program will also provide a forum for the next generation of scientists who are active in the vaccinology field, to present their data in oral or poster presentations, discuss with peers and senior scientists, and advance their careers, be it in academia, industry, or government. ISV’s Bright Sparks in Vaccinology competition acknowledges student and postdoc presentations in parallel sessions of the oral program to support the participation and careers of next generation vaccinologists. To strengthen their professional advancements, the ISV Congress, building on its long-standing commitment to mentoring, dedicate a session to career development opportunities, bringing together junior and senior scientists in an interactive atmosphere. To stimulate the participation of young scientists, which has always been successful in the past, the ISV has a policy of inexpensive registration rates for PhD students and provides Travel Awards to selected junior scientists (based upon abstract submission and review for quality) to help defray costs of in-person and virtual participation. Prizes for best presentations or oral abstracts and poster abstracts are a high priority of the ISV Officers, who volunteer to review and rank all presentations during the ongoing conference to select winners and runners up based on abstract quality and presentation skills, and present award certificates to the prize winners.

项目摘要/摘要 国际疫苗协会(ISV)是一个非营利性的成员组织，成立于 1992年，成员来自44个国家，自2007年以来每年举行一次大会。借助ISV 年度大会，来自五大洲的成员和非成员出席， 该协会旨在突出疫苗研究的最新突破性进展， 制造、临床开发和实施，以及安全性。全体会议是 致力于横跨疫苗学不同领域的当前热门话题，包括针对 具有挑战性的目标，基于T细胞的疫苗，建立B细胞记忆，基于结构 疫苗设计、粘膜疫苗和针对新发传染病的疫苗。ISV 大会作为主要的综合性非商业疫苗会议，努力确保 来自不同背景的发言者和代表的参与(学术界、工业界、 政府和基金会)。分组会议包括与佐剂相关的主题 机制，同一健康，人畜共患感染疫苗，以及下一代疫苗。 这些领域的知名特邀演讲者已经并将被邀请为 每一次全体会议议题，辅之以从提交的 摘要。该计划还将为下一代科学家提供一个论坛，这些科学家 活跃在疫苗领域，以口头或海报形式展示他们的数据，与 同行和资深科学家，并推进他们的职业生涯，无论是在学术界、工业界还是 政府。ISV在疫苗学竞赛中发出光明的火花，承认学生和博士后 在口头方案的平行会议上发言，以支持以下人员的参与和事业 下一代疫苗专家。为了加强他们的职业发展，ISV 国会在其长期致力于指导的基础上，专门举办了一次关于职业生涯的会议 发展机会，将初级和高级科学家聚集在一起进行互动 大气层。激发青年科学家的参与，这一直是 ISV在过去取得了成功，它的政策是为博士生提供廉价的注册率 并向选定的初级科学家提供旅行奖(基于摘要提交和 审查质量)，以帮助支付面对面参与和虚拟参与的成本。最佳奖 介绍或口头摘要和海报摘要是ISV官员的高度优先事项，他们 志愿者在正在进行的会议期间对所有演示文稿进行评审和排名，以选出获胜者 根据抽象质量和演示技巧获得亚军，并颁发获奖证书 敬获奖者。